Corona Remedies IPO Allotment Update: GMP Hints at Strong 28% Listing Jump
The Corona Remedies IPO has become one of the most talked‑about public offerings on the Indian markets this December. Investors are watching closely. We from the investing community have seen strong demand, huge subscription numbers, and a rising Grey Market Premium (GMP). These trends point to a likely good debut on the listing day.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
